We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
BBVU offers laboratory reference services and carries out research and development on hepatitis viruses, and has a remit for blood safety.
How to get a marketing authorisation for an Advanced Therapy Medicinal Product (ATMP) so it can be sold and/or supplied in Great Britain.
Millions at risk from 'silent killer' as NHS campaign warns there are often 'no clues' when it comes to high blood pressure.
Bilateral model health certificates for exports of live animals and animal products to Great Britain, the Channel Islands and the Isle of Man.
NDNS results assessing diet, nutrient intake, nutritional status of the population in private households in the UK aged 18 months upwards.
TACO is one of the most common causes of transfusion-related deaths in the UK and cases have increased substantially in recent years. Identifying risk factors for TACO prior to transfusion allows initiation of appropriate mitigating measures.
Data on blood folate concentrations published as part of the National Diet and Nutrition Survey (NDNS).
This overview is aimed at professionals working in the NHS newborn blood spot (NBS) screening programme.
Information and service documents on the national DBS testing service offered by PHE to improve uptake of 12 month testing of infants born to hepatitis B infected mothers.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
The Brucella Reference Unit (BRU) provides laboratory diagnostic and clinical management services for Brucella species.
This professional resource outlines how providers and commissioners can reduce blood pressure in the population.
Guidance and calculators for working out nutrient budgets for proposed developments on 27 specific habitats sites.
How to import animals and animal products to Great Britain (England, Scotland and Wales), the Channel Islands and the Isle of Man from non-EU countries.
Advice and guidance on the health needs of migrant patients from Eritrea for healthcare practitioners.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.